PDE5 inhibitors
Showing 1 - 25 of >10,000
ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin
Active, not recruiting
- Pulmonary Arterial Hypertension
- PDE5 inhibitor
- Endothelin Receptor Antagonists
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Erectile Dysfunction Trial in Banha (OnabotulinumtoxinA, Trimix)
Recruiting
- Erectile Dysfunction
- OnabotulinumtoxinA
- Trimix
-
Banha, Kalubiaya, EgyptBanha University Hospitals
Jan 6, 2022
Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))
Recruiting
- Erectile Dysfunction
- PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
- PDE5 inhibitor (tadalafil)
-
Saint Petersburg, Russian FederationSBPSU
Apr 10, 2023
Cystic Fibrosis Trial in Denver, Augusta (Sildenafil 40mg oral capsule, Placebo Oral capsule)
Recruiting
- Cystic Fibrosis
- Sildenafil 40mg oral capsule
- Placebo Oral capsule
-
Denver, Colorado
- +1 more
Aug 29, 2022
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Healthy, Obese Trial in Nashville (Tadalafil, Placebo)
Completed
- Healthy
- Obese
- Tadalafil
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 3, 2022
Obesity Trial in Nashville (Tadalafil 20 MG, Placebo)
Recruiting
- Obesity
- Tadalafil 20 MG
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 29, 2022
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Carotid Artery Intima Media Thickness Can Predict Response to
Completed
- Erectile Dysfunction Due to Arterial Disease
- CIMT (Carotid artery intima media thickness measurement)
-
Bursa, TurkeyBursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023
Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on
Completed
- Pulmonary Arterial Hypertension
- no intervention, only observation of different groups
-
Heidelberg, GermanyCentre for pulmonary hypertension, Thoraxclinic at the Universit
Jan 24, 2020
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)
Not yet recruiting
- Single-ventricle
- +2 more
- Sildenafil
- Placebos
- (no location specified)
Jan 20, 2022
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Learn About Use and Effects of CDK4/6 Inhibitors in Canadian
Active, not recruiting
- Breast Cancer
-
Kirkland, Quebec, CanadaPfizer Canada
Mar 5, 2023
Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Completed
- Erectile Dysfunction
- +2 more
- no intervention
- (no location specified)
Jul 15, 2021
Renal Transplant Failure Trial in Vancouver (Sildenafil)
Not yet recruiting
- Renal Transplant Failure
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Nov 3, 2020
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Retinitis Pigmentosa Trial in Nantes (AAV2/5-hPDE6B)
Active, not recruiting
- Retinitis Pigmentosa
- AAV2/5-hPDE6B
-
Nantes, FranceClinique Ophtalmologique, CHU de Nantes
Feb 28, 2022
Diabete Type 2 Trial in El Sadat (Sitagliptin 50 mg, Empagliflozin 12.5 MG, Sitagliptin 50 mg + Empagliflozin 12.5 MG)
Completed
- Diabete Type 2
- Sitagliptin 50 mg
- +3 more
-
El Sadat, EgyptUniversity of Sadat City
Apr 27, 2022
Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))
Not yet recruiting
- Generalized Myasthenia Gravis
- zilucoplan (RA101495)
- (no location specified)
Aug 22, 2022
Premature Ejaculation Trial (Sildenafil 50 mg, Placebo, Tramadol Hydrochloride 100 MG)
Not yet recruiting
- Premature Ejaculation
- Sildenafil 50 mg
- +2 more
- (no location specified)
Dec 21, 2021
PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)
Recruiting
- PCO
- Dapagliflozin 5 MG
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university
Oct 26, 2022